Developer docs
API playgroundTry for free, no card

Search company profiles

Pharma intelligence

Full company profile

uuid0008szs

Namestring
Pharma intelligence
Company typeenum
Private
Founded yearint
1997
Descriptiontext

Pharma Intelligence is a London-headquartered provider of data, analytics, insight, and consultancy services to pharmaceutical, MedTech, and clinical research organizations. Founded in 1998, it operates within the Informa group (evidenced by its pharmaintelligence.informa.com domain) and serves enterprise customers across the drug development and clinical research value chain, including pipeline intelligence, clinical trial monitoring, therapeutic-area analytics, and strategic advisory work.

Its core product surface is delivered under the Citeline brand, with Clinical Intelligence as a flagship offering focused on clinical and drug development data. The company has progressively broadened its scope through M&A — notably the February 2021 acquisition of TrialScope, which added clinical trial disclosure and compliance capabilities — suggesting a deliberate strategy to bundle intelligence, compliance, and consultancy into an integrated offering for R&D-driven buyers. The combination of specialized therapeutic-area expertise (e.g., dedicated leadership in Oncology and Respiratory) with broad horizontal coverage indicates a vertically nuanced go-to-market targeting enterprise pharma and CRO procurement rather than long-tail SMB volume.

The business model is anchored in enterprise B2B subscriptions and licensing of proprietary clinical and commercial intelligence, supplemented by bespoke consultancy engagements. Pricing details, contract structures, and channel mix are not disclosed in the available source material, limiting deeper revenue mechanics visibility. With a workforce of 1,001–5,000 employees and over 25 years of operational history, Pharma Intelligence presents as a mature, scaled franchise rather than an early-stage growth asset.

Short descriptiontext

Pharma Intelligence, founded in 1998 and headquartered in London, provides data, analytics, insight, and consultancy services to pharmaceutical, MedTech, and clinical research organizations, with Clinical Intelligence (Citeline) as its core offering.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical intelligence, clinical research analytics, MedTech consultancy, drug development data, healthcare market insight
Industry1 code
PRIMARYHLACAKAL
Medication Analytics, Outcomes & Cost Optimization
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
NAICS code2 codes
  • Software Publishers51321
  • Marketing Research and Public Opinion Polling541910
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Intelligence & Analytics
Social media profiles2 records
Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Pharma Intelligence provides analysis, insight, and consultancy services for pharmaceutical, MedTech, and clinical research organizations. It delivers data-driven intelligence products such as Clinical Intelligence (under the Citeline brand) to support decision-making across the drug development lifecycle.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Clinical Intelligence
CategoryClinical & Pharmaceutical Intelligence
Description

A data and intelligence platform offered under the Citeline brand focused on the pharmaceutical and clinical research domain, providing insights to support drug development and clinical decision-making for pharma, biotech, and MedTech organizations.

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor providing pharma intelligence, drug pipeline, clinical trial, and regulatory data through Cortellis and other products. Closest comparable in pharma life science intelligence with overlapping product portfolio and customer base.

TypeDirect peer
Description

Largest direct competitor combining clinical research services with proprietary data assets including claims, prescription, and clinical trial data. Broader scale but overlaps significantly in pharma intelligence and clinical research data services.

TypeDirect peer
Description

Direct competitor providing pharma commercial intelligence, consensus forecasts, and drug pipeline data. Owned by Norstella, focused specifically on pharma data services with comparable customer base among pharma commercial teams.

TypeDirect peer
Description

Adis division provides pharma intelligence, drug evaluation, and clinical research information. Direct competitor in pharma decision-support intelligence serving similar pharma and MedTech customers.

5Elsevier
TypeBroad incumbent
Description

Provides Embase and other life science databases serving pharma and clinical research. Broader academic publisher with overlapping pharma intelligence offerings and similar customer base among pharma R&D and medical affairs teams.

TypeDirect peer
Description

Provides commercial intelligence for healthcare and life sciences organizations. Comparable in providing analytics and intelligence to pharma and MedTech customers, with overlap in healthcare commercial data and analytics.

TypeDirect peer
Description

Provides data, analytics, and insights across multiple industries including pharma. Direct competitor in pharma market intelligence, drug pipeline analysis, and clinical trial data services.

TypeEmerging player
Description

Specialized in pharma commercial intelligence, market access, and consulting. Smaller, more focused peer with overlapping customer base in pharma commercial and market access teams.

TypeBroad incumbent
Description

Provides healthcare and pharma insights, market research, and consulting. Broader market research firm with significant pharma practice, overlapping in pharma insights and market research services.

TypeBroad incumbent
Description

Provides real-world evidence and patient data for pharma. Now part of ICON, broadens clinical research and data services scope with comparable customer base among pharma commercial and R&D teams.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharma intelligence

Pharmaceutical Intelligence & Analyticspharmaintelligence.informa.com

Pharma Intelligence, founded in 1998 and headquartered in London, provides data, analytics, insight, and consultancy services to pharmaceutical, MedTech, and clinical research organizations, with Clinical Intelligence (Citeline) as its core offering.

What Pharma intelligence does

Pharma Intelligence is a London-headquartered provider of data, analytics, insight, and consultancy services to pharmaceutical, MedTech, and clinical research organizations. Founded in 1998, it operates within the Informa group (evidenced by its pharmaintelligence.informa.com domain) and serves enterprise customers across the drug development and clinical research value chain, including pipeline intelligence, clinical trial monitoring, therapeutic-area analytics, and strategic advisory work.

Its core product surface is delivered under the Citeline brand, with Clinical Intelligence as a flagship offering focused on clinical and drug development data. The company has progressively broadened its scope through M&A — notably the February 2021 acquisition of TrialScope, which added clinical trial disclosure and compliance capabilities — suggesting a deliberate strategy to bundle intelligence, compliance, and consultancy into an integrated offering for R&D-driven buyers. The combination of specialized therapeutic-area expertise (e.g., dedicated leadership in Oncology and Respiratory) with broad horizontal coverage indicates a vertically nuanced go-to-market targeting enterprise pharma and CRO procurement rather than long-tail SMB volume.

The business model is anchored in enterprise B2B subscriptions and licensing of proprietary clinical and commercial intelligence, supplemented by bespoke consultancy engagements. Pricing details, contract structures, and channel mix are not disclosed in the available source material, limiting deeper revenue mechanics visibility. With a workforce of 1,001–5,000 employees and over 25 years of operational history, Pharma Intelligence presents as a mature, scaled franchise rather than an early-stage growth asset.

Pharma intelligence firmographics

Firmographics
Name
Pharma intelligence
Website
https://pharmaintelligence.informa.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
101–250 employees
Short description
Pharma Intelligence, founded in 1998 and headquartered in London, provides data, analytics, insight, and consultancy services to pharmaceutical, MedTech, and clinical research organizations, with Clinical Intelligence (Citeline) as its core offering.
Ownership category
akta.pro rank

Pharma intelligence industry classification

Industry
Product category
Pharmaceutical Intelligence & Analytics
NAICS
Software Publishers (51321), Marketing Research and Public Opinion Polling (541910)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLACAKAL
Medication Analytics, Outcomes & Cost Optimization
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

  • Pharmaceutical intelligence
  • Clinical research analytics
  • MedTech consultancy
  • Drug development data
  • Healthcare market insight

Where Pharma intelligence is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

Pharma intelligence business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Pharma intelligence product offering

Product offering

Core offering

Pharma Intelligence provides analysis, insight, and consultancy services for pharmaceutical, MedTech, and clinical research organizations. It delivers data-driven intelligence products such as Clinical Intelligence (under the Citeline brand) to support decision-making across the drug development lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Intelligence A data and intelligence platform offered under the Citeline brand focused on the pharmaceutical and clinical research domain, providing insights to support drug development and clinical decision-making for pharma, biotech, and MedTech organizations.

Companies that use Pharma intelligence

Customer profile

Ideal customer profiles1 record

Pharma intelligence technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Pharma intelligence partnerships and signals

Strategic signal

Expansion highlights3 records

Pharma intelligence competitors and assessment

Company assessment

Direct peers

  • Clarivate: Direct competitor providing pharma intelligence, drug pipeline, clinical trial, and regulatory data through Cortellis and other products. Closest comparable in pharma life science intelligence with overlapping product portfolio and customer base.
  • IQVIA: Largest direct competitor combining clinical research services with proprietary data assets including claims, prescription, and clinical trial data. Broader scale but overlaps significantly in pharma intelligence and clinical research data services.
  • Evaluate (Norstella): Direct competitor providing pharma commercial intelligence, consensus forecasts, and drug pipeline data. Owned by Norstella, focused specifically on pharma data services with comparable customer base among pharma commercial teams.
  • Springer Nature (Adis): Adis division provides pharma intelligence, drug evaluation, and clinical research information. Direct competitor in pharma decision-support intelligence serving similar pharma and MedTech customers.
  • Definitive Healthcare: Provides commercial intelligence for healthcare and life sciences organizations. Comparable in providing analytics and intelligence to pharma and MedTech customers, with overlap in healthcare commercial data and analytics.
  • GlobalData: Provides data, analytics, and insights across multiple industries including pharma. Direct competitor in pharma market intelligence, drug pipeline analysis, and clinical trial data services.

Broad incumbents

  • Elsevier: Provides Embase and other life science databases serving pharma and clinical research. Broader academic publisher with overlapping pharma intelligence offerings and similar customer base among pharma R&D and medical affairs teams.
  • Kantar Health: Provides healthcare and pharma insights, market research, and consulting. Broader market research firm with significant pharma practice, overlapping in pharma insights and market research services.
  • Symphony Health (ICON): Provides real-world evidence and patient data for pharma. Now part of ICON, broadens clinical research and data services scope with comparable customer base among pharma commercial and R&D teams.

Emerging players

  • Trinity Life Sciences: Specialized in pharma commercial intelligence, market access, and consulting. Smaller, more focused peer with overlapping customer base in pharma commercial and market access teams.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

Pharma intelligence social profiles

Digital presence

Pharma intelligence financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharma intelligence leadership team

Management profile

Number of profiles

Profiles1 record

Pharma intelligence funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharma intelligence M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma intelligence

What does Pharma intelligence do?

Pharma Intelligence provides analysis, insight, and consultancy services for pharmaceutical, MedTech, and clinical research organizations. It delivers data-driven intelligence products such as Clinical Intelligence (under the Citeline brand) to support decision-making across the drug development lifecycle.

When was Pharma intelligence founded?

Pharma intelligence was founded in 1997. It employs 101 to 250 people.

Where is Pharma intelligence based?

Pharma intelligence is headquartered in New York, United States, in the North America region.

Who are Pharma intelligence's main competitors?

Direct peers on record are Clarivate, IQVIA, Evaluate (Norstella), Springer Nature (Adis), Definitive Healthcare and GlobalData. Broad incumbents are Elsevier, Kantar Health and Symphony Health (ICON). Trinity Life Sciences is listed as an emerging player.

Does Pharma intelligence have an API?

No public API is recorded for Pharma intelligence.

What industry is Pharma intelligence in?

Pharma intelligence's product category is Pharmaceutical Intelligence & Analytics. Its primary akta.pro industry code is HLACAKAL, Medication Analytics, Outcomes & Cost Optimization. Its NAICS code is 51321 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Datasemantics10 Analytics Use Cases Every Pharma & Healthcare CIO Should ChampionAnalytics is being leveraged across various areas in the pharmaceutical and healthcare industries, including drug discovery, clinical trial optimization, supply chain improvement, and personalized medicine. Companies are using predictive analytics and machine learning to enhance efficiency, reduce costs, and improve patient outcomes, indicating a significant evolution in the way these sectors operate. This trend reflects a broader movement towards data-driven decision-making in healthcare.GlobeNewswirePharma Intelligence Unveils Its Rebrand to Citeline Following Transition to Independent CompanyPharma Intelligence has rebranded to Citeline following Warburg Pincus' acquisition of the business from Informa PLC, making it an independent company. The Citeline product suite maintains its leading position in clinical trial intelligence, covering more than 375,000 clinical trials across 180 countries. The company plans to fully implement its new brand identity over the coming months, including new logo, website, and brand elements.GlobeNewswirePharma Intelligence Unveils Its Rebrand to Citeline Following Transition to Independent CompanyPharma Intelligence rebranded to Citeline after Warburg Pincus acquired it from Informa PLC. The company's product suite covers over 375,000 clinical trials across 180 countries. New branding elements, including logo and website, will be announced.YahooPharma Intelligence Unveils Its Rebrand to Citeline Following Transition to Independent CompanyPharma Intelligence has officially rebranded to Citeline, marking its transition into an independent company following its acquisition by Warburg Pincus from Informa PLC. The new entity will continue to provide clinical trial intelligence and data services under the Citeline name, which was previously one of its leading product suites. This move signifies a strategic shift towards independence and accelerated growth in the pharmaceutical research sector.GlobeNewswirePharma Intelligence Appoints General Counsel, ChiefPharma Intelligence, acquired by Warburg Pincus, appointed Vicky Harris as General Counsel and Jeff Huntsman as Chief Commercial Officer. Harris previously led legal at Clarivate, while Huntsman served as SVP of global sales there and previously held roles at Connective RX and Parexel. The appointments aim to support customer needs and continued growth.GlobeNewswireCompletion of Pharma Intelligence Acquisition by Warburg Pincus From Informa PLC and Appointment of Executive ChairWarburg Pincus completed its acquisition of Pharma Intelligence from Informa PLC, with Mubadala Investment Company joining as a co-investor. Informa retains a 15% equity stake, and Jay Nadler was appointed Executive Chair. The company plans to invest in innovation to expand in the $22 billion pharmaceutical data and analytics market.GlobeNewswireCompletion of Pharma Intelligence Acquisition by Warburg Pincus From Informa PLC and Appointment of Executive ChairWarburg Pincus completed its acquisition of Pharma Intelligence from Informa PLC, with Mubadala Investment Company joining as a co-investor. Informa retains a 15% equity stake, and Jay Nadler was appointed Executive Chair. The company plans to focus on innovation and product development in the $22 billion pharmaceutical data and analytics market.Warburg PincusWarburg Pincus Announces Acquisition Of Pharma Intelligence From InformaWarburg Pincus acquired Pharma Intelligence from Informa, with Mubadala joining as investor. Informa retains 15% ownership. The deal is expected to complete in the first half of 2022.PR NewswireWARBURG PINCUS ANNOUNCES ACQUISITION OF PHARMA INTELLIGENCE FROM INFORMAWarburg Pincus acquired Pharma Intelligence from Informa, with Mubadala joining as investor. Informa retains 15% ownership. The deal is expected to close in the first half of 2022.London Business NewsPfizer/BioNTech and Moderna to earn $14.7bn from vaccine sales by 2023 - London Business NewsPfizer-BioNTech and Moderna COVID-19 vaccines are projected to generate $14.7bn in sales by 2023, with Moderna expected to lead at $3.5bn in 2021. AstraZeneca has the most ordered doses, while Pfizer's vaccine faces ultra-cold storage challenges. China administered nearly one-third of global doses as of January 2021.